Skip to main content
Body
   
  • crop_skinny_new_green.png
    View Recording
  • crop_skinny_new_green.png
    Learn More
  • crop_skinny_new_green.png
    Capsules
  • crop_skinny_new_green.png
    Featured Teams
  • crop_skinny_new_green.png
    Accurate Blood Pressure
    Measurement
  • crop_skinny_new_green.png
    Listen Now
  • Sharing Best Practices to Improve
    Cardiovascular and Diabetes Health
Body

Race as a Social Construct: Serving the Needs of All Individuals

 

Race is a social construct that is broadly used to categorize people based on physical characteristics, behavioral patterns, and geographic location. Race is not a proxy for biology or genetics. Data regarding race is typically based on self-identification and data collection routinely allows respondents to select more than one race. Racial and ethnic groups that have historically faced discrimination are at a higher risk for cardiovascular disease and diabetes. Ohio Department of Medicaid recognizes that social inequality, not genetic differences, produce these racial and ethnic health disparities. Examining health access, health care quality, and health outcome data by race and ethnicity allows the health system to assist in addressing the factors contributing to inequity and ensure that the health system serves the needs of all individuals. October 2021

For more information, please contact Melissa Nance, ODM Quality Improvement Section Chief (Melissa.Nance@medicaid.ohio.gov).


 

Sharing best practices to improve cardiovascular and diabetes health.

 
Founded in 2017, the mission of Cardi-OH is to improve cardiovascular and diabetes health outcomes and eliminate disparities in Ohio's Medicaid population.

 

 
Body

MOST RECENT

Four Drugs Found Beneficial for Glycemic Reduction in Patients with Type 2 Diabetes

In the recent Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE), all four drugs compared (insulin glargine, glimepiride, liraglutide, and sitagliptin) had a beneficial effect on glycemic reduction.1 Glargine and liraglutide performed best, both in achieving and sustaining glycemic outcomes. Of note, severe hypoglycemia was more common in the glimepiride (2.2%) and insulin (1.3%) groups; liraglutide was associated with more weight loss.

READ MORE →

Body
What We Do

What We Do


Experts at Ohio's seven medical schools identify, produce, and disseminate the latest evidence-based cardiovascular and diabetes best practices.

 

How We Do It Icon

 

 

How We Do It


Utilize monthly newsletters and an online repository of resources at Cardi-OH.org, podcasts available on Cardi-OH Radio, and the Project ECHO® virtual training model.

Why We Do It

Why We Do It


To improve the health and well-being of all Ohioans.

Body

 
Body

 

© 2020 Cardi-OH

 

Body
Body